“While the findings suggest that some people taking GLP-1 receptor agonists may experience fewer respiratory attacks, this ...

(Ian Hooton/SPL/Getty Images) A fatal asthma attack appears to be a disaster contained entirely within the chest. The airways ...

Key Takeaways The GLP-1 medication semaglutide may benefit lung healthSemaglutide was linked to nearly 40% fewer asthma ...

Semaglutide and Asthma? The popular GLP-1 diabetes and weight-loss injection may be linked to fewer asthma attacks and COPD ...

Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study.

The single most important diagnostic tool for asthma is a thorough history and physical examination. Often, a primary care ...

Recent findings show GLP-1s users experience fewer asthma attacks. More studies are needed to confirm a link.

The diabetes and weight-loss injection semaglutide can reduce asthma attacks by up to 40%, according to research presented at ...

Amid unmistakable benefits to drugs like Wegovy and Ozempic, including less asthma, COPD attacks, there are some reasons to ...

Today we feature data from studies being presented at the ongoing European Respiratory Society Congress in Barcelona.

The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. The analysis demonstrated a half-life of up to ...

In July 2026, Belenos’ partner Keymed Biosciences received Breakthrough Therapy Designation in China for BEL512, for the treatment of CRSwNP.